id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0611-0001,FDA,FDA-2011-D-0611,Draft Guidance for Industry on Biosimilars: Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009; Availability,Notice,Notice of Availability,2012-02-15T05:00:00Z,2012,2,2012-02-15T05:00:00Z,2012-04-17T03:59:59Z,2012-05-12T12:01:36Z,2012-03549,0,0,0900006480fb722f
FDA-2011-D-0611-0002,FDA,FDA-2011-D-0611,Guidance for Industry on Implementation of Biologics Price Competition and Innovation Act of 2009; Draft Guidance,Other,Guidance,2012-02-15T05:00:00Z,2012,2,2012-02-15T05:00:00Z,,2019-11-18T16:52:17Z,,0,0,0900006480fb7017